Singapore markets open in 3 hours 51 minutes

ORIC Pharmaceuticals, Inc. (ORIC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.95+0.93 (+8.44%)
At close: 04:00PM EST
11.95 0.00 (0.00%)
After hours: 04:01PM EST
Full screen
Trade prices are not sourced from all markets
Previous close11.02
Open11.05
Bid11.99 x 800
Ask12.05 x 800
Day's range11.05 - 12.06
52-week range4.09 - 13.42
Volume398,310
Avg. volume416,590
Market cap801.27M
Beta (5Y monthly)0.99
PE ratio (TTM)N/A
EPS (TTM)-1.98
Earnings date14 Mar 2024 - 18 Mar 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est16.14
  • GlobeNewswire

    ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit

    SOUTH SAN FRANCISCO and SAN DIEGO, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in a fireside chat at the Citi 2024 Virtual Oncology Leadership Summit on Wednesday, February 21, 2024, at 3:00 p.m. ET. A live webcast of the discussion will be available through the investor section of the company’s web

  • GuruFocus.com

    ORIC Pharmaceuticals CEO Jacob Chacko Sells 40,000 Shares

    On February 7, 2024, Jacob Chacko, the President and CEO of ORIC Pharmaceuticals Inc (NASDAQ:ORIC), executed a sale of 40,000 shares of the company, according to a recent SEC Filing.

  • Zacks

    Recent Price Trend in Oric Pharmaceuticals, Inc. (ORIC) is Your Friend, Here's Why

    Oric Pharmaceuticals, Inc. (ORIC) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.